In this issue:
Oral vitamin D3 for chronic plaque psoriasis
Trough adalimumab serum levels and PASI score
Low-dose methotrexate after etanercept treatment failure
Apremilast in psoriasis
Biologics combination therapy
Comparative effectiveness of targeted immunomodulators
Paradoxical ulcerative colitis during adalimumab treatment
Th17 inhibitors in active psoriatic arthritis
Ixekizumab for moderate-to-severe psoriasis
Serum leptin, resistin and adiponectin concentrations in psoriasis
Please login below to download this issue (PDF)